India  
 
NewsR.in

Stopped producing Covishield in Dec 2021: SII after AstraZeneca recall

IndiaTimes Wednesday, 8 May 2024
UK-based drug major AstraZeneca's decision to withdraw its Covid-19 vaccine globally, days after admitting to side effects, prompted Serum Institute of India to disclose that it had stopped manufacturing Covishield in Dec 2021 due to a fall in demand as well as the emergence of new variants. Covishield accounted for nearly 80% of Covid-19 vaccine doses administered in India.
0
shares		ShareTweetSavePostSend
 

💡 newsR Knowledge: Other News Mentions

AstraZeneca AstraZeneca British pharmaceutical company

Dominica to honour PM for aid during pandemic

 Indian Prime Minister Narendra Modi is set to receive Dominica's highest civilian award, the Dominica Award of Honour. The award recognizes Modi's contributions..
IndiaTimes

You Might Like


Related videos from verified sources

Covishield: Parents File Lawsuit Against Serum Institute Amid AstraZeneca’s Report| Oneindia [Video]

Covishield: Parents File Lawsuit Against Serum Institute Amid AstraZeneca’s Report| Oneindia

After AstraZeneca's acknowledgment of rare side effects, parents of a woman allegedly deceased post-Covishield vaccination initiated legal action against Serum Institute of India. Covishield, developed..

Credit: Oneindia     Duration: 03:03Published